StockMacro
Menu

Profound Medical

$6.38 -5.8% in 6 monthsMarket cap $233.7M

PROF on XNAS, Health Care, Profound Medical Corp., job postings

Measures activity, not value. Not investment advice.

Twelve-month revenue rose 65% to $23.6M, but the company lost $32.5M while the stock rose 8.6% in a year.

  • Watch2 director or officer changes filed in the last 90 days

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
162
Website
profoundmedical.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 4 Mar 2027 (an estimate: a year ago it reported on 5 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $9.8M, net loss $7.7M.
Quarter to 31 Mar 2024: revenue $1.4M, net income -$6.6MQuarter to 31 Mar 2024: revenue $1.4M, net income -$6.6MQuarter to 30 Jun 2024: revenue $2.2M, net income -$6.9MQuarter to 30 Jun 2024: revenue $2.2M, net income -$6.9MQuarter to 30 Sep 2024: revenue $2.8M, net income -$9.4MQuarter to 30 Sep 2024: revenue $2.8M, net income -$9.4MQuarter to 31 Dec 2024: revenue $4.2M, net income -$4.9MQuarter to 31 Dec 2024: revenue $4.2M, net income -$4.9MQuarter to 31 Mar 2025: revenue $2.6M, net income -$10.7MQuarter to 31 Mar 2025: revenue $2.6M, net income -$10.7MQuarter to 30 Jun 2025: revenue $2.2M, net income -$15.7MQuarter to 30 Jun 2025: revenue $2.2M, net income -$15.7MQuarter to 30 Sep 2025: revenue $5.3M, net income -$8.0MQuarter to 30 Sep 2025: revenue $5.3M, net income -$8.0MQuarter to 31 Dec 2025: revenue $6.0M, net income -$8.2MQuarter to 31 Dec 2025: revenue $6.0M, net income -$8.2MQuarter to 31 Mar 2026: revenue $5.3M, net income -$7.1MQuarter to 31 Mar 2026: revenue $5.3M, net income -$7.1MQuarter to 30 Jun 2026: revenue $2.5M, net income -$9.5MQuarter to 30 Jun 2026: revenue $2.5M, net income -$9.5MQuarter to 30 Sep 2026: revenue $9.8M, net income -$7.7MQuarter to 30 Sep 2026: revenue $9.8M, net income -$7.7M
31 Mar 2024RevenueNet incomeNet losstallest bar $15.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$9.8M-$7.7M
30 Jun 2026$2.5M-$9.5M
31 Mar 2026$5.3M-$7.1M
31 Dec 2025$6.0M-$8.2M
30 Sep 2025$5.3M-$8.0M
30 Jun 2025$2.2M-$15.7M
31 Mar 2025$2.6M-$10.7M
31 Dec 2024$4.2M-$4.9M
30 Sep 2024$2.8M-$9.4M
30 Jun 2024$2.2M-$6.9M
31 Mar 2024$1.4M-$6.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $23.6M $14.3M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +65% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$32.5M -$39.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 73.9% 72.5% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -145% -295% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -138% -275% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -87.0% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $33.3M $24.8M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $4.5M $4.5M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$28.8M (net cash) -$20.3M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.11 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.16
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 9.9 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 8.7 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 5.5 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Profound MedicalPROF (this company) $233.7Mloss9.9+65%-138%
OraSure TechnologiesOSUR $238.9Mloss2.1-7.5%-41.7%
ClearPoint NeuroCLPT $221.5Mloss4.9+33%-79.4%
Orthofix MedicalOFIX $247.4Mloss0.30+2.1%-5.4%
SS Innovations InternationalSSII $254.9Mloss5.5+27%-31.5%
Pro-Dex Inc NewPDEX $201.6M16.82.5+13%15.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+5.5%

58 13F filers vs 55

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

44%

16.1M shares held by 13F filers (30 Sep 2026) of 36.6M outstanding (5 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.3%

1.6M shares sold short (30 Oct 2026) of 36.6M outstanding (5 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

9.8

1.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+1.4%

1.6M shares sold short in the report before, 1.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

48%

48% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

11

11 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.5×

11 articles in the last 7 days; its usual week has 2.

Price $6.38 on 20 Nov 2026, +8.6% over 12 months (12-month range $5.06 to $8.65)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $100K).
Revenue per quarter. Revenue $9.8M in the latest quarter, +86% on a year earlier.
Institutional holders (13F filers). 58 13F filers reported holding it in the latest 13F quarter, +41% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, capital spending per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
12 Nov 20268-K and other filingsRichard R. Fabian named President and CEO Jan 15, 2027, succeeding Arun Menawat; Matthew Sobczyk appointed CFO; director Cynthia Lavoie resigned, replaced by Jason Mills
3 Sep 20268-K and other filingsDirector or officer change
17 Aug 20268-K and other filingsDirector or officer change
17 Aug 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 May 2026Sharp changeShort interest spike: short interest spike, 2.3M vs usual 844K (2026-04-30); 4.7x the same period a year earlier
14 Apr 2026Sharp changeShort interest spike: short interest spike, 2.1M vs usual 736K (2026-03-31); 4.3x the same period a year earlier
31 Mar 2026Sharp changeShort interest spike: short interest spike, 1.8M vs usual 691K (2026-03-13); 3.7x the same period a year earlier
10 Mar 20268-K and other filingsDirector or officer change
10 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Feb 2026Sharp changeMany funds opening a new position: many funds opening a new position, 20 vs usual 5.50 (2025-12-31); 1.4x the same period a year earlier
30 Dec 2025Sharp changeShort interest spike: short interest spike, 1.1M vs usual 564K (2025-12-15); 3.0x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 641K vs usual 380K (2025-07-31); 1.8x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 614K vs usual 374K (2025-07-15); 1.8x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 592K vs usual 360K (2025-06-13); 1.9x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 535K vs usual 354K (2025-05-30); 1.8x the same period a year earlier
7 Mar 20258-K and other filingsEarlier financial statements can no longer be relied on
1 Mar 2022Sharp changeShort interest spike: short interest spike, 997K vs usual 516K (2022-02-15); 3.1x the same period a year earlier
Insider net buying (open market)
Month from 1 May 2025: $100K published
Revenue per quarter
Quarter ended 31 Mar 2024: $1.4M; public on 9 May 2025
Quarter ended 30 Jun 2024: $2.2M; public on 15 Aug 2025
Quarter ended 30 Sep 2024: $2.8M; public on 14 Nov 2025
Quarter ended 31 Dec 2024: $4.2M; public on 8 Mar 2025
Quarter ended 31 Mar 2025: $2.6M, +82% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $2.2M, -1.0% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $5.3M, +87% on a year earlier; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $6.0M, +43% on a year earlier; public on 6 Mar 2026
Quarter ended 31 Mar 2026: $5.3M, +104% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $2.5M, +12% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $9.8M, +86% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 45; public on 14 Feb 2022
31 Mar 2022 report: 40; public on 16 May 2022
30 Jun 2022 report: 36; public on 15 Aug 2022
30 Sep 2022 report: 33; public on 14 Nov 2022
31 Dec 2022 report: 31; public on 14 Feb 2023
31 Mar 2023 report: 28; public on 15 May 2023
30 Jun 2023 report: 29; public on 14 Aug 2023
30 Sep 2023 report: 29; public on 14 Nov 2023
31 Dec 2023 report: 43; public on 14 Feb 2024
31 Mar 2024 report: 41; public on 15 May 2024
30 Jun 2024 report: 38; public on 14 Aug 2024
30 Sep 2024 report: 42; public on 14 Nov 2024
31 Dec 2024 report: 52; public on 14 Feb 2025
31 Mar 2025 report: 49; public on 15 May 2025
30 Jun 2025 report: 43; public on 14 Aug 2025
30 Sep 2025 report: 41; public on 14 Nov 2025
31 Dec 2025 report: 60; public on 17 Feb 2026
31 Mar 2026 report: 56; public on 15 May 2026
30 Jun 2026 report: 55; public on 14 Aug 2026
30 Sep 2026 report: 58; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is cash from operations, fiscal year at -$38.2M (31 Dec 2025), 66% below its normal quarter of -$23.0M.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: $100K).
  • Revenue per quarter: Revenue $9.8M in the latest quarter, +86% on a year earlier.
  • Institutional holders (13F filers): 58 13F filers reported holding it in the latest 13F quarter, +41% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 1 insider trades

No trades in the last 90 days; the latest was filed 20 May 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 May 2025Arun Swarup MenawatCEOBuy22,030$4.55$100KForm 4

58 institutions reported shares at the end of Q3 2026, 44% of the shares outstanding; 8 opened a position, 6 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FIL Ltd2.4M6.54%$13.9M+25K+1.1%
Gagnon Securities LLC2.1M5.60%$11.9M+91K+4.6%
Royce & Associates LP1.2M3.31%$7.1M+12K+1.0%
Timelo Investment Management Inc.1.0M2.77%$5.9M-101K-9.1%
Gagnon Advisors, LLC962K2.63%$5.6MNo change
Letko, Brosseau & Associates Inc936K2.55%$5.2MNo change
Rosalind Advisors, Inc.828K2.26%$4.8MNo change
Z3 Capital Partners, LLC783K2.14%$4.5M-38K-4.6%
MMCAP International Inc. SPC671K1.83%$3.9MNo change
Ardsley Advisory Partners LP575K1.57%$3.3MNo change

Company events

All 10 company events

In 12 months: 4 director or officer changes, 3 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
12 Nov 2026Richard R. Fabian named President and CEO Jan 15, 2027, succeeding Arun Menawat; Matthew Sobczyk appointed CFO; director Cynthia Lavoie resigned, replaced by Jason Mills8-K
3 Nov 2026Signed a major agreement8-K
3 Sep 2026Director or officer change8-K
17 Aug 2026Director or officer change8-K
10 Mar 2026Director or officer change8-K
30 Dec 2025Signed a major agreementSame filing: sold shares privately8-K
19 Dec 2025Signed a major agreement8-K
7 Mar 2025Signed a major agreement; Earlier financial statements can no longer be relied onSame filing: took on new debt8-K

The 5 newest of 114 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 12 Nov 2026Filings record

    Richard R. Fabian named President and CEO Jan 15, 2027, succeeding Arun Menawat; Matthew Sobczyk appointed CFO; director Cynthia Lavoie resigned, replaced by Jason Mills

  2. 3 Sep 2026Filings record

    Director or officer change

  3. 17 Aug 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 17 Aug 2026Filings record

    Director or officer change

  5. 12 May 2026Short interest and volume change

    had 2.3M shares sold short in the 30 Apr 2026 report, 4.7× the same report last year.

    Same report last year: 494K; its normal report is 844K.

    See the evidence
    This period
    2.3M (the 30 Apr 2026 report)
    Normal report (median of 24 earlier)
    844K
    Typical spread (median absolute deviation)
    272K
    How far from its usual level
    +3.7
    Same report last year
    494K
    History used
    2,373 days
    2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K2025-06-13: 592K2025-06-30: 612K2025-07-15: 614K2025-07-31: 641K2025-08-15: 623K2025-08-29: 690K2025-09-15: 692K2025-09-30: 781K2025-10-15: 794K2025-10-31: 893K2025-11-14: 954K2025-11-28: 1.1M2025-12-15: 1.1M2025-12-31: 1.2M2026-01-15: 1.1M2026-01-30: 1.3M2026-02-13: 1.4M2026-02-27: 1.5M2026-03-13: 1.8M2026-03-31: 2.1M2026-04-15: 2.1M2026-04-30: 2.3M
    the 30 Apr 2026 report24 earlier reportsnormal: 844K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 11 Apr 2026Short interest and volume change

    had 2.1M shares sold short in the 31 Mar 2026 report, 4.3× the same report last year.

    Same report last year: 493K; its normal report is 736K.

    See the evidence
    This period
    2.1M (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    736K
    Typical spread (median absolute deviation)
    230K
    How far from its usual level
    +4.0
    Same report last year
    493K
    History used
    2,343 days
    2025-03-31: 493K2025-04-15: 492K2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K2025-06-13: 592K2025-06-30: 612K2025-07-15: 614K2025-07-31: 641K2025-08-15: 623K2025-08-29: 690K2025-09-15: 692K2025-09-30: 781K2025-10-15: 794K2025-10-31: 893K2025-11-14: 954K2025-11-28: 1.1M2025-12-15: 1.1M2025-12-31: 1.2M2026-01-15: 1.1M2026-01-30: 1.3M2026-02-13: 1.4M2026-02-27: 1.5M2026-03-13: 1.8M2026-03-31: 2.1M
    the 31 Mar 2026 report24 earlier reportsnormal: 736K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 25 Mar 2026Short interest and volume change

    had 1.8M shares sold short in the 13 Mar 2026 report, 3.7× the same report last year.

    Same report last year: 488K; its normal report is 691K.

    See the evidence
    This period
    1.8M (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    691K
    Typical spread (median absolute deviation)
    198K
    How far from its usual level
    +3.7
    Same report last year
    488K
    History used
    2,325 days
    2025-03-14: 488K2025-03-31: 493K2025-04-15: 492K2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K2025-06-13: 592K2025-06-30: 612K2025-07-15: 614K2025-07-31: 641K2025-08-15: 623K2025-08-29: 690K2025-09-15: 692K2025-09-30: 781K2025-10-15: 794K2025-10-31: 893K2025-11-14: 954K2025-11-28: 1.1M2025-12-15: 1.1M2025-12-31: 1.2M2026-01-15: 1.1M2026-01-30: 1.3M2026-02-13: 1.4M2026-02-27: 1.5M2026-03-13: 1.8M
    the 13 Mar 2026 report24 earlier reportsnormal: 691K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 10 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 10 Mar 2026Filings record

    Director or officer change

  10. 17 Feb 2026Institutional holdings change

    saw 20 13F filers open a new position in the quarter ended 31 Dec 2025, 1.4× the same quarter last year.

    Same quarter last year: 14; its normal quarter is 5.5.

    See the evidence
    This period
    20 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    5.5
    Typical spread (median absolute deviation)
    1.5
    How far from its usual level
    +4.8
    Same quarter last year
    14
    History used
    3,653 days
    2023-12-31: 122024-03-31: 42024-06-30: 42024-09-30: 72024-12-31: 142025-03-31: 72025-06-30: 42025-09-30: 42025-12-31: 20
    the quarter ended 31 Dec 20258 earlier quartersnormal: 5.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  11. 25 Dec 2025Short interest and volume change

    had 1.1M shares sold short in the 15 Dec 2025 report, 3.0× the same report last year.

    Same report last year: 378K; its normal report is 564K.

    See the evidence
    This period
    1.1M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    564K
    Typical spread (median absolute deviation)
    107K
    How far from its usual level
    +3.5
    Same report last year
    378K
    History used
    2,237 days
    2024-12-13: 378K2024-12-31: 370K2025-01-15: 382K2025-01-31: 345K2025-02-14: 383K2025-02-28: 475K2025-03-14: 488K2025-03-31: 493K2025-04-15: 492K2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K2025-06-13: 592K2025-06-30: 612K2025-07-15: 614K2025-07-31: 641K2025-08-15: 623K2025-08-29: 690K2025-09-15: 692K2025-09-30: 781K2025-10-15: 794K2025-10-31: 893K2025-11-14: 954K2025-11-28: 1.1M2025-12-15: 1.1M
    the 15 Dec 2025 report24 earlier reportsnormal: 564K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 12 Aug 2025Short interest and volume change

    had 641K shares sold short in the 31 Jul 2025 report, 1.8× the same report last year.

    Same report last year: 366K; its normal report is 380K.

    See the evidence
    This period
    641K (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    380K
    Typical spread (median absolute deviation)
    43K
    How far from its usual level
    +4.0
    Same report last year
    366K
    History used
    2,100 days
    2024-07-31: 366K2024-08-15: 354K2024-08-30: 354K2024-09-13: 318K2024-09-30: 341K2024-10-15: 335K2024-10-31: 341K2024-11-15: 348K2024-11-29: 338K2024-12-13: 378K2024-12-31: 370K2025-01-15: 382K2025-01-31: 345K2025-02-14: 383K2025-02-28: 475K2025-03-14: 488K2025-03-31: 493K2025-04-15: 492K2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K2025-06-13: 592K2025-06-30: 612K2025-07-15: 614K2025-07-31: 641K
    the 31 Jul 2025 report24 earlier reportsnormal: 380K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 25 Jul 2025Short interest and volume change

    had 614K shares sold short in the 15 Jul 2025 report, 1.8× the same report last year.

    Same report last year: 341K; its normal report is 374K.

    See the evidence
    This period
    614K (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    374K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +4.7
    Same report last year
    341K
    History used
    2,084 days
    2024-07-15: 341K2024-07-31: 366K2024-08-15: 354K2024-08-30: 354K2024-09-13: 318K2024-09-30: 341K2024-10-15: 335K2024-10-31: 341K2024-11-15: 348K2024-11-29: 338K2024-12-13: 378K2024-12-31: 370K2025-01-15: 382K2025-01-31: 345K2025-02-14: 383K2025-02-28: 475K2025-03-14: 488K2025-03-31: 493K2025-04-15: 492K2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K2025-06-13: 592K2025-06-30: 612K2025-07-15: 614K
    the 15 Jul 2025 report24 earlier reportsnormal: 374K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 26 Jun 2025Short interest and volume change

    had 592K shares sold short in the 13 Jun 2025 report, 1.9× the same report last year.

    Same report last year: 319K; its normal report is 360K.

    See the evidence
    This period
    592K (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    360K
    Typical spread (median absolute deviation)
    22K
    How far from its usual level
    +4.6
    Same report last year
    319K
    History used
    2,052 days
    2024-06-14: 319K2024-06-28: 346K2024-07-15: 341K2024-07-31: 366K2024-08-15: 354K2024-08-30: 354K2024-09-13: 318K2024-09-30: 341K2024-10-15: 335K2024-10-31: 341K2024-11-15: 348K2024-11-29: 338K2024-12-13: 378K2024-12-31: 370K2025-01-15: 382K2025-01-31: 345K2025-02-14: 383K2025-02-28: 475K2025-03-14: 488K2025-03-31: 493K2025-04-15: 492K2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K2025-06-13: 592K
    the 13 Jun 2025 report24 earlier reportsnormal: 360K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 11 Jun 2025Short interest and volume change

    had 535K shares sold short in the 30 May 2025 report, 1.8× the same report last year.

    Same report last year: 303K; its normal report is 354K.

    See the evidence
    This period
    535K (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    354K
    Typical spread (median absolute deviation)
    21K
    How far from its usual level
    +3.6
    Same report last year
    303K
    History used
    2,038 days
    2024-05-31: 303K2024-06-14: 319K2024-06-28: 346K2024-07-15: 341K2024-07-31: 366K2024-08-15: 354K2024-08-30: 354K2024-09-13: 318K2024-09-30: 341K2024-10-15: 335K2024-10-31: 341K2024-11-15: 348K2024-11-29: 338K2024-12-13: 378K2024-12-31: 370K2025-01-15: 382K2025-01-31: 345K2025-02-14: 383K2025-02-28: 475K2025-03-14: 488K2025-03-31: 493K2025-04-15: 492K2025-04-30: 494K2025-05-15: 477K2025-05-30: 535K
    the 30 May 2025 report24 earlier reportsnormal: 354K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 21 May 2025Insiders record

    Menawat Arun Swarup (CEO) bought 22,030 shares of PROF ($100,201) (dated 20 May 2025)

  17. 7 Mar 2025Filings record

    Earlier financial statements can no longer be relied on

  18. 26 Feb 2022Short interest and volume change

    had 997K shares sold short in the 15 Feb 2022 report, 3.1× the same report last year.

    Same report last year: 323K; its normal report is 516K.

    See the evidence
    This period
    997K (the 15 Feb 2022 report)
    Normal report (median of 24 earlier)
    516K
    Typical spread (median absolute deviation)
    70K
    How far from its usual level
    +4.6
    Same report last year
    323K
    History used
    838 days
    2021-01-29: 336K2021-02-12: 323K2021-02-26: 327K2021-03-15: 448K2021-03-31: 426K2021-04-15: 431K2021-04-30: 441K2021-05-14: 547K2021-05-28: 588K2021-06-15: 546K2021-06-30: 514K2021-07-15: 531K2021-07-30: 526K2021-08-13: 509K2021-08-31: 499K2021-09-15: 500K2021-09-30: 481K2021-10-15: 517K2021-10-29: 615K2021-11-15: 529K2021-11-30: 589K2021-12-15: 622K2022-01-14: 738K2022-01-31: 821K2022-02-15: 997K
    the 15 Feb 2022 report24 earlier reportsnormal: 516K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 5 Oct 2017Filings record

    Private placement of securities (Form D)

Not listed: 30 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001628808
Ticker
PROF
Domain
profoundmedical.com
Hq location
A6|MISSISSAUGA|L4W 5 (1 unverified)
Name
Profound Medical Corp.
  • SEC Form 13F institutional holdings396 data points31 Dec 2015 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)36 records5 Oct 2017 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)197 data points31 Dec 2019 to 5 Nov 2026
  • SEC Form 4 insider transactions1 record, 4 data points20 May 2025 to 20 May 2025
  • FINRA short interest (twice monthly)504 data points31 Oct 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3550 data points29 Oct 2019 to 20 Nov 2026